Transparency
We believe in providing an open environment to help build a foundation of trust and respect among our colleagues, healthcare professionals, patients, stockholders, and the public. Making information available is important as we continue to operate our business to the highest standards, and in keeping with current laws and regulations.
We are firmly focused on Our mission and take our responsibility for transparency seriously. Sustainability reporting is a clear example of an area in which we will continue to work to increase transparency as we show progress towards our Sustainability goals (on our U.S. corporate site).
Australia interactions with healthcare professionals
Bristol Myers Squibb is widely recognised for excellence in providing some of the world's most important medicines for patients. At the same time, we strive to be transparent by providing information about treatments we are studying, whether they are investigational compounds, or new indications for existing marketed products.
At Bristol Myers Squibb we work in partnership with many organisations and individuals to meet the needs of patients. Bristol Myers Squibb is committed to working in partnership with others in a way which is fully compliant with the Medicines Australia's Code of Conduct. Our objective is to act ethically and transparently with our stakeholders and the wider community. Information on the transparency requirements under the Medicines Australia Code of Conduct can be found in the links below or on the Medicines Australia Website.
Please use the links below for further information:
Bristol Myers Squibb prepares reports for publication in accordance with the Medicines Australia Code of Conduct and Australia’s Privacy legislation. The reports are publicly available for three years from the date of first publication.
There are 3 reports required to be prepared:
- Transfers of Value to Healthcare Professionals
- Sponsorship of Third Party Educational Meetings and Symposia
- Health Consumer Organisation Support
The Transfers of Value to Healthcare Professionals report is published every 6 months and the information is held in a searchable database administered by Medicines Australia. It covers all transfers of value associated with honoraria, airfares, accommodation, and registration provided to Healthcare Professionals who are identified by name in the report. For further information about the details disclosed in the report or to search the database, please visit Disclosure Australia.
The Sponsorship of Third Party Educational Meetings and Symposia report is published every 6 months on the Medicines Australia Third Party Meeting Sponsorship page, and covers support provided by pharmaceutical companies for independently organised educational events.
The Health Consumer Organisation Support report is an annual report also published on the Medicines Australia website and covers financial and/or any significant non-financial support provided to organisations that work for the benefit of Australian patients. For more information on the disclosable details and to view published reports, please visit Health Consumer Organisation Support Report.
If you have a question about transactions reported by Bristol Myers Squibb, email your inquiries to: